Aspire BioPharma is trading at $8.30 (-8.99%) amid broader risk-off sentiment following hotter producer inflation and geopolitical tensions; no new company-specific announcement was identified on September 10, 2026.
- The Nasdaq fell 0.99% and the S&P 500 fell 0.55%.
- The latest identified filing, dated September 8, concerned an earlier press release.